Evidence map›Paper›PMID 29908566›Full record

ArticleMicrobial cell factories2018

Production of the compatible solute α-D-glucosylglycerol by metabolically engineered Corynebacterium glutamicum.

Benjamin Roenneke, Natalie Rosenfeldt, Sami M Derya, Jens F Novak, Kay Marin, Reinhard Krämer, Gerd M Seibold

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Salt-TolerantFrontiers in microbiology · 2021
    Article
  7. Exploring the Potential ofFrontiers in bioengineering and biotechnology · 2021
    Article
  8. The Industrial OrganismAntioxidants (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Benjamin RoennekeInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Natalie RosenfeldtInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Sami M DeryaInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Jens F NovakInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Kay MarinInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Reinhard KrämerInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany.
Gerd M SeiboldInstitute of Biochemistry, University of Cologne, Zülpicher Str. 47, 50674, Cologne, Germany. gerd.seibold@uni-ulm.de.ORCID http://orcid.org/0000-0002-9823-8134
University of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundα-D-Glucosylglycerol (αGG) has beneficial functions as a moisturizing agent in cosmetics and potential as a health food material, and therapeutic agent. αGG serves as compatible solute in various halotolerant cyanobacteria such as Synechocystis sp. PCC 6803, which synthesizes αGG in a two-step reaction: The enzymatic condensation of ADP-glucose and glycerol 3-phosphate by GG-phosphate synthase (GGPS) is followed by the dephosphorylation of the intermediate by the GG-phosphate phosphatase (GGPP). The Gram-positive Corynebacterium glutamicum, an industrial workhorse for amino acid production, does not utilize αGG as a substrate and was therefore chosen for the development of a heterologous microbial production platform for αGG.

resultsPlasmid-bound expression of ggpS and ggpP from Synechocystis sp. PCC 6803 enabled αGG synthesis exclusively in osmotically stressed cells of C. glutamicum (pEKEx2-ggpSP), which is probably due to the unique intrinsic control mechanism of GGPS activity in response to intracellular ion concentrations. C. glutamicum was then engineered to optimize precursor supply for αGG production: The precursor for αGG synthesis ADP-glucose gets metabolized by both the glgA encoded glycogen synthase and the otsA encoded trehalose-6-phosphate synthase. Upon deletion of both genes the αGG concentration in culture supernatants was increased from 0.5 mM in C. glutamicum (pEKEx3-ggpSP) to 2.9 mM in C. glutamicum ΔotsA IMglgA (pEKEx3-ggpSP). Upon nitrogen limitation, which inhibits synthesis of amino acids as compatible solutes, C. glutamicum ΔotsA IMglgA (pEKEx3-ggpSP) produced more than 10 mM αGG (about 2 g L

conclusionsCorynebacterium glutamicum can be engineered as efficient platform for the production of the compatible solute αGG. Redirection of carbon flux towards αGG synthesis by elimination of the competing pathways for glycogen and trehalose synthesis as well as optimization of nitrogen supply is an efficient strategy to further optimize production of αGG.

Indexed as

Corynebacterium glutamicumGlucosidesGlycogenMetabolic EngineeringTrehaloseGlucosidesglucosylglycerolGlycogenTrehaloseCompatible soluteCorynebacterium glutamicumGlycogenTrehaloseα-D-Glucosylglycerol

Identifiers

PMID29908566
PMCPMC6004087
OpenAlexW2807776469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.